Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.
about
Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer ProgressionDiversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular PerspectivesMultipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technologyGenetically modified mesenchymal stromal cells in cancer therapyThe Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with InflammationSystemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse ModelsNano-engineered skin mesenchymal stem cells: potential vehicles for tumour-targeted quantum-dot deliveryCryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy.Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.Current status and future prospects of mesenchymal stem cell therapy for liver fibrosisTNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophilsChemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.Stem cell-based therapies for tumors in the brain: are we there yet?Harnessing mesenchymal stem cell homing as an anticancer therapy.Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology.Mesenchymal Stem Cells Promote Metastasis of Lung Cancer Cells by Downregulating Systemic Antitumor Immune ResponseCXCR4 antagonists suppress small cell lung cancer progression.Dux4 controls migration of mesenchymal stem cells through the Cxcr4-Sdf1 axis.Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype.Skin-derived mesenchymal stem cells as quantum dot vehicles to tumors.Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells.Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications.Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer.Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells.Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth
P2860
Q26750318-CFA3F887-9670-449D-A81B-CDE490C291EAQ26770002-7D4736B3-BDDF-480F-8F1D-1B82947F0300Q26782778-62C30D9B-8862-4D17-8E72-3B071A8D4414Q26798274-45996A1A-4609-4D67-9CEB-502C9366B64EQ26821929-4BA95655-D02E-46D5-9198-6C90A17AA7C9Q28071840-1017EC11-0B95-4E18-BBB7-50969A08C408Q28073691-47ED45A1-55A7-475C-95C4-2513AEBB7664Q33722638-37036720-8D0D-4FB2-AB19-5B419A0F71A6Q33824175-0EFF48C9-0175-488F-B385-D804543A7F33Q37000249-95D49318-77BA-4546-A428-8A3EF0B5D706Q37014210-A34682E3-D12F-424D-9442-4D7C296EC5D4Q37430773-C26D8741-6C21-4698-8D25-AF84872E7D68Q37622200-679B2287-1B53-4794-803B-021FC2388A8AQ38803932-92692065-E269-443C-967F-82328DDF34B3Q38855638-86889C8A-8E67-4891-AE90-52E4BC4FF8B6Q38857484-FF5243D9-8E9C-4F1D-8D33-8EBC7235C6E0Q40109819-DFE1BABA-52E5-4C4C-B41D-1662009FAECAQ41169407-2FEDF920-97A9-442D-A381-91B5813F2EFBQ42089559-45F45AF5-C500-42DD-8B1E-56284862EBB4Q42320215-5B71065A-131B-4363-8125-87F128637D86Q42654111-AF5B242C-2F62-4742-A583-446456859FAEQ47133839-E5F4F2BC-FF61-4FD8-A8CF-089DF994C167Q47638547-1E8D0A8F-E3A8-4B3A-B463-30C1415228E6Q47701410-596C5FF9-98D2-4884-9678-7B12A35F6014Q50075766-CCEFF737-86DB-42A6-8E60-2B5DCEE39B4EQ52668037-1C8C84E5-9F8A-4350-BF9D-C5008FBA79BEQ58760128-00D37851-C5C1-4159-A515-C85E5C7D32EC
P2860
Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Macrophage migration inhibitor ...... em cell recruitment to tumors.
@ast
Macrophage migration inhibitor ...... em cell recruitment to tumors.
@en
type
label
Macrophage migration inhibitor ...... em cell recruitment to tumors.
@ast
Macrophage migration inhibitor ...... em cell recruitment to tumors.
@en
prefLabel
Macrophage migration inhibitor ...... em cell recruitment to tumors.
@ast
Macrophage migration inhibitor ...... em cell recruitment to tumors.
@en
P2093
P2860
P50
P356
P1476
Macrophage migration inhibitor ...... tem cell recruitment to tumors
@en
P2093
R Andres Floto
Sofia Lourenco
Vitor H Teixeira
P2860
P304
P356
10.4049/JIMMUNOL.1402097
P407
P577
2015-02-23T00:00:00Z